Comparable monthly disclosures
Institutional Activity
Where disclosed mutual fund positions are increasing, reducing, opening or closing.
Portfolio increases
Apr 2025 · Ranked across companies with at least 10 comparable portfolios
| Company | Portfolio increases | Comparable change | Portfolios increasing | Portfolios reducing | Comparable portfolios |
|---|---|---|---|---|---|
| Ajanta Pharma Limited AJANTPHARM | 29 39.2% of comparable | -0.03 Cr | 29 | 8 | 74 |
| Bank of India BANKINDIA | 29 50.9% of comparable | +0.67 Cr | 29 | 8 | 57 |
| GlaxoSmithKline Pharmaceuticals Limited GLAXO | 29 52.7% of comparable | +0.01 Cr | 29 | 9 | 55 |
| ABB India Limited ABB | 29 26.1% of comparable | -0.01 Cr | 29 | 13 | 111 |
| Godrej Properties Limited GODREJPROP | 29 34.9% of comparable | +0.04 Cr | 29 | 14 | 83 |
| Bosch Limited BOSCHLTD | 29 40.8% of comparable | -17,830 | 29 | 16 | 71 |
| Godrej Consumer Products Limited GODREJCP | 29 24.2% of comparable | -74,082 | 29 | 24 | 120 |
| UNO Minda Limited UNOMINDA | 28 29.5% of comparable | +0.05 Cr | 28 | 2 | 95 |
| Bandhan Bank Limited BANDHANBNK | 28 38.9% of comparable | -0.10 Cr | 28 | 11 | 72 |
| Laurus Labs Limited LAURUSLABS | 28 46.7% of comparable | -0.13 Cr | 28 | 14 | 60 |
| Vishal Mega Mart Limited VMM | 27 45.0% of comparable | +1.67 Cr | 27 | 2 | 60 |
| CESC Limited CESC | 27 42.2% of comparable | +0.18 Cr | 27 | 3 | 64 |
| Zensar Technologies Limited ZENSARTECH | 27 50.9% of comparable | +0.02 Cr | 27 | 3 | 53 |
| Tata Chemicals Limited TATACHEM | 27 69.2% of comparable | -0.07 Cr | 27 | 4 | 39 |
| Emami Limited EMAMILTD | 27 38.6% of comparable | +0.10 Cr | 27 | 5 | 70 |
| Bajaj Holdings & Investment Limited BAJAJHLDNG | 27 56.2% of comparable | +27,361 | 27 | 8 | 48 |
| Steel Authority of India Limited SAIL | 27 41.5% of comparable | -0.95 Cr | 27 | 9 | 65 |
| Cyient Limited CYIENT | 27 43.5% of comparable | +0.02 Cr | 27 | 10 | 62 |
| UPL Limited UPL | 27 38.0% of comparable | -0.14 Cr | 27 | 12 | 71 |
| Cohance Lifesciences Limited COHANCE | 27 35.1% of comparable | -0.03 Cr | 27 | 15 | 77 |
| Natco Pharma Limited NATCOPHARM | 26 89.7% of comparable | +15,303 | 26 | 0 | 29 |
| Affle 3i Limited AFFLE | 26 43.3% of comparable | -96,593 | 26 | 3 | 60 |
| Premier Energies Limited PREMIERENE | 26 46.4% of comparable | +0.07 Cr | 26 | 3 | 56 |
| Kajaria Ceramics Limited KAJARIACER | 26 39.4% of comparable | +0.51 Cr | 26 | 3 | 66 |
| Swiggy Limited SWIGGY | 26 31.0% of comparable | +0.70 Cr | 26 | 5 | 84 |
How to read this activity
Activity compares disclosed positions for economic portfolios observed in both relevant monthly disclosures and adjusts for externally evidenced corporate actions where available.
At least 10 comparable portfolios are required. Companies under corporate-action review are excluded. Counts are unweighted by portfolio size, and share changes are quantities rather than market values; zero counts can appear at the end of a ranking. Breadth change is the change in AMCs holding, and can also reflect reporting coverage.
Full methodology →